Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

BiomEdit acquires Folium Science's technology assets

PRIVATEAug 25, 2026about 3 hours ago

Acquiring Company

BiomEdit

Acquired Company

Folium Science

IndianaBiotechnologyHealth CareBiotechnologyHealth Care

Description

BiomEdit has acquired Folium Science's technology platform and pipeline assets, including the poultry feed additive BiomElix® One. This acquisition enhances BiomEdit's capabilities with CRISPR-based microbiome technology. The combined expertise is aimed at improving animal health and production challenges.

Company Information

Company

BiomEdit

Location

Indiana, United States

About

BiomEdit is a pioneering animal health biotechnology company focused on developing innovative solutions for livestock production. Their lead product, BE-101, is the first engineered probiotic biologic designed to combat necrotic enteritis in broiler chickens. BiomEdit aims to enhance poultry health through sustainable, non-antibiotic approaches. The company is advancing toward commercialization with the support of notable investors and strategic partnerships.

Don't miss BiomEdit's next move

Get an email the moment BiomEdit makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Eric
Likely contact at this company
••••••••@••••••••

See Eric's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for BiomEdit's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Folium Science?

Folium Science was acquired by BiomEdit, based in Indiana. The deal was reported on August 25, 2026. BiomEdit is a pioneering animal health biotechnology company focused on developing innovative solutions for livestock production. BiomEdit is privately held and operates in Biotechnology.

When did BiomEdit acquire Folium Science?

BiomEdit's acquisition of Folium Science was reported on August 25, 2026. BiomEdit has acquired Folium Science's technology platform and pipeline assets, including the poultry feed additive BiomElix® One. This acquisition enhances BiomEdit's capabilities with CRISPR-based microbiome technology. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Folium Science do?

Folium Science has developed precision microbiome technologies including the Guided Biotics® CRISPR-Cas technology. The company focuses on improving animal health through innovative scientific approaches. It is privately held, operating in Biotechnology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.